Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.

PLoS One · 2017 · PMC5242484 · PMID 28099502

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a clear trendp = 0.06so close (0.05 < p ≤ 0.1)

A clear trend (p = 0.06) to an increase in absolute numbers of NK-T cells (CD3+CD16+CD56+) was observed after cycle 1 compared to baseline in Group A ( Fig 4A ) and after adding of gemcitabine, the numbers of NKT cells was reduced (p<0.05).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.